Amyloid Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Amyloid Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy [NA]
A completed clinical trial evaluating the SGLT-2 inhibitor dapagliflozin in patients with amyloid cardiomyopathy across heart failure phenot…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant [Phase 3]
This entry notes that Acoramidis is being evaluated in a Phase 3 ACT-EARLY prevention trial in asymptomatic carriers of pathogenic TTR varia…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy [Phase 4]
Phase 4 clinical trial evaluating enavogliflozin for amyloid cardiomyopathy; status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
This item provides a status update on the Swiss Cardiac Amyloidosis Registry (Swiss-CARE). It is a clinical research registry sponsored by I…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Open-Label Study of AG10 in Patients with Cardiomyopathy [Phase 2]
Open-label Phase 2 study of AG10 in patients with amyloid cardiomyopathy is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) [NA]
This entry describes the EOSS-ATTR Study, an eHealth-based operative support system trial for transthyretin amyloid cardiomyopathy (ATTR-CM)…